Position in GSK
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$4,162,043
-$219,932 QoQ
Shares Held
79,398
0.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#173
of 1,032 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cohen Klingenstein LLC holds $217,553,450 across 9 Drug Manufacturers - General names. GSK ranks #5 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
129,013 | $154,742,075 | |
| 2 | JNJ |
Johnson & Johnson
|
127,994 | $32,506,636 | |
| 3 | AMGN |
Amgen Inc
|
31,270 | $11,323,492 | |
| 4 | ABBV |
AbbVie Inc.
|
18,000 | $4,529,520 | |
| 5 | GSK |
GSK plc
This page
|
79,398 | $4,162,043 | |
| 6 | PFE |
Pfizer Inc
|
169,014 | $4,069,857 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
47,559 | $2,740,349 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
20,700 | $2,615,238 |
All Filings in GSK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,162,043 | 79,398 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $4,381,975 | 79,398 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $3,893,677 | 79,398 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $3,426,817 | 79,398 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $3,048,883 | 79,398 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $3,075,878 | 79,398 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $3,321,056 | 98,198 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $4,264,274 | 104,312 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $4,047,890 | 105,140 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $5,073,235 | 118,340 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $4,593,216 | 123,940 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $4,797,325 | 132,340 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $5,286,837 | 148,340 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $5,277,937 | 148,340 | Shares | Sole | 2023-04-14 | |
| 2022-12-31 | $5,212,667 | 148,340 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $4,979,291 | 169,191 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $9,029,828 | 211,500 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $9,036,051 | 211,500 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $9,148,068 | 211,500 | Shares | Sole | 2022-01-14 | |
| 2021-09-30 | $9,800,070 | 261,500 | Shares | Sole | 2021-10-15 | |
| 2021-06-30 | $10,495,372 | 268,730 | Shares | Sole | 2021-07-16 | |
| 2021-03-31 | $9,406,827 | 268,730 | Shares | Sole | 2021-04-15 | |
| 2020-12-31 | $9,699,390 | 268,730 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $9,920,789 | 268,730 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $10,751,035 | 268,730 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $9,986,681 | 268,730 | Shares | Sole | 2020-04-15 | |
| No filing history on record for this holder in this stock. | ||||||